Jane Street’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.27M Buy
+1,425,270
New +$884K ﹤0.01% 4948
2026
Q1
Sell
-104,662
Closed -$45.2K 12611
2025
Q4
$165K Buy
104,662
+78,837
+305% +$126K ﹤0.01% 9870
2025
Q3
$27.4K Sell
25,825
-44,982
-64% -$77.8K ﹤0.01% 10478
2025
Q2
$113K Buy
+70,807
New +$113K ﹤0.01% 8901
2025
Q1
Sell
-26,218
Closed -$49.6K 10295
2024
Q4
$49.6K Buy
26,218
+15,008
+134% +$61.7K ﹤0.01% 8971
2024
Q3
$59.9K Buy
11,210
+1,001
+10% +$7.33K ﹤0.01% 9136
2024
Q2
$75.3K Sell
10,209
-3,339
-25% -$26.8K ﹤0.01% 8827
2024
Q1
$162K Buy
13,548
+10,904
+412% +$88.2K ﹤0.01% 8306
2023
Q4
$20.8K Buy
+2,644
New +$22.4K ﹤0.01% 8903
2023
Q3
Sell
-1,182
Closed -$41.1K 9166
2023
Q2
$41.1K Buy
+1,182
New +$32.2K ﹤0.01% 8251
2023
Q1
Sell
-889
Closed -$19.2K 9686
2022
Q4
$19.2K Buy
889
+361
+68% +$7.85K ﹤0.01% 8620
2022
Q3
$13K Buy
+528
New +$12.3K ﹤0.01% 9294
2022
Q2
Sell
-4,077
Closed -$145K 10532
2022
Q1
$145K Buy
+4,077
New +$127K ﹤0.01% 9260
2021
Q3
Sell
-3,198
Closed -$160K 10510
2021
Q2
$160K Buy
+3,198
New +$148K ﹤0.01% 8996
2019
Q4
Sell
-889
Closed -$26K 5549
2019
Q3
$26K Buy
+889
New +$34.3K ﹤0.01% 4942

Other funds holding OTLK

Jane Street's OTLK Position: Q2 2026 in Review

Jane Street opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 1,425,270 shares worth $2.27M. The stake represents ﹤0.01% of the portfolio and ranks #4948 among its holdings. This is a return to the name: Jane Street previously reported a position in OTLK as recently as Q4 2025.

Jane Street first reported a position in OTLK in Q3 2019 and has held it in 15 quarters since. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Jane Street held 1,425,270 shares of Outlook Therapeutics worth $2.27M as of Q2 2026.
  • Outlook Therapeutics was a new Jane Street position in Q2 2026.
  • Outlook Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4948 holding.
  • Jane Street first reported a position in Outlook Therapeutics in Q3 2019 and has held it in 15 quarters since.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.